Exparel 266 MG/20 ML vial 20ML
Ended Awarded Last action
- Contract number
- SPE2DR26FKKH1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,005
Award facts
- Contract value 100% obligated
- $41,004.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $41,004.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order was awarded on December 17, 2025, with an ultimate completion date of January 9, 2026, and carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. The product will be delivered to Park Ridge, Illinois, and fulfills pharmaceutical supply needs within the Defense Logistics Agency's medical supply chain operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical sourcing for military healthcare facilities. The underlying IDC, valued at $499,999,999 through December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor capable of supplying branded and generic prescription medications, biologics, and medical consumables to support Department of Defense healthcare operations globally. EXPAREL, a specialty surgical anesthetic product, exemplifies the vendor's portfolio of high-value pharmaceutical products supporting military medical requirements.
Quick answers
Who was awarded contract SPE2DR26FKKH1?
SPE2DR26FKKH1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FKKH1 worth?
The government has obligated $41,005 on SPE2DR26FKKH1.
Is contract SPE2DR26FKKH1 an order under another contract?
Yes. SPE2DR26FKKH1 is a delivery order under SPE2DR25D9367, an indefinite delivery contract.
Was contract SPE2DR26FKKH1 competed?
The extent of competition for SPE2DR26FKKH1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award